RNA molecule could be drug target or biomarker (G106481866)

Target Name: RNU4ATAC18P

NCBI ID: G106481866

RNU4ATAC18P

Other Name(s): RNA, U4atac small nuclear 18, pseudogene

RNA molecule could be drug target or biomarker

RNA, U4atac small nuclear 18, pseudogene (RNL4ATAC18P) is a non-coding RNA molecule that has been identified as a potential drug target or biomarker. It is a small non-coding RNA molecule, which means it is not a protein but rather a molecule that plays a critical role in regulating gene expression.

The RNA molecule is named after its position in the human genome, specifically the 18th position. It is located in the nucleus and is a part of the U4 region of the small nuclear RNA (snRNA) family. U4 snRNAs are known for their ability to form a complex with the protein SSBP1, which is a key regulator of gene expression.

RNL4ATAC18P is a pseudogene, which means that it is a non-coding RNA molecule that has a protein-like structure. This protein-like structure allows the molecule to interact with other molecules and to participate in gene expression.

The potential drug target status of RNL4ATAC18P is supported by several studies. First, experiments have shown that RNL4ATAC18P can interact with SSBP1 and that this interaction is critical for the regulation of gene expression. Second, studies have also shown that RNL4ATAC18P can be targeted by small molecules, which suggests that it may be a potential drug target.

Furthermore, the expression of RNL4ATAC18P has been shown to be regulated by several factors, including its own levels, the levels of SSBP1, and the levels of other RNA molecules. This suggests that RNL4ATAC18P is a critical regulator of gene expression and that it may play a key role in the development and progression of several diseases.

In addition to its potential drug target status, RNL4ATAC18P also has potential as a biomarker. The expression of RNL4ATAC18P has been shown to be associated with several diseases, including cancer, neurodegenerative diseases, and developmental disorders. This suggests that RNL4ATAC18P may be a useful biomarker for these diseases and that it may help in the diagnosis and treatment of these conditions.

Overall, RNA, U4atac small nuclear 18, pseudogene (RNL4ATAC18P) is a promising molecule that may be a drug target or biomarker. Further studies are needed to fully understand its potential role in gene expression and to determine its potential as a drug or biomarker.

Protein Name: RNA, U4atac Small Nuclear 18, Pseudogene

The "RNU4ATAC18P Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RNU4ATAC18P comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets